Sajjadi, E.; Sharif-Paghaleh, E.; Akrami, M.; Shahpasand, K.; Haririan, I.; Maghsoudian, S.
Development and Evaluation of “a PEGylated Anti-Tau ScFv for SPECT Imaging” in a Rat Model of Traumatic Brain Injury. Pharmaceutics 2026, 18, 626.
https://doi.org/10.3390/pharmaceutics18050626
AMA Style
Sajjadi E, Sharif-Paghaleh E, Akrami M, Shahpasand K, Haririan I, Maghsoudian S.
Development and Evaluation of “a PEGylated Anti-Tau ScFv for SPECT Imaging” in a Rat Model of Traumatic Brain Injury. Pharmaceutics. 2026; 18(5):626.
https://doi.org/10.3390/pharmaceutics18050626
Chicago/Turabian Style
Sajjadi, Esmat, Ehsan Sharif-Paghaleh, Mohammad Akrami, Koorosh Shahpasand, Ismaeil Haririan, and Samane Maghsoudian.
2026. "Development and Evaluation of “a PEGylated Anti-Tau ScFv for SPECT Imaging” in a Rat Model of Traumatic Brain Injury" Pharmaceutics 18, no. 5: 626.
https://doi.org/10.3390/pharmaceutics18050626
APA Style
Sajjadi, E., Sharif-Paghaleh, E., Akrami, M., Shahpasand, K., Haririan, I., & Maghsoudian, S.
(2026). Development and Evaluation of “a PEGylated Anti-Tau ScFv for SPECT Imaging” in a Rat Model of Traumatic Brain Injury. Pharmaceutics, 18(5), 626.
https://doi.org/10.3390/pharmaceutics18050626